ClinicalResearch News & Analysis

AstraZeneca Partners With Oracle to Enhance Clinical Research Using AI

AstraZeneca has entered into a partnership with Oracle to improve its clinical research processes using artificial intelligence (AI). The collaboration aims to leverage AI technology to refine data analysis and optimize the efficiency of clinical trials. Oracle’s AI capabilities will support AstraZeneca in managing and interpreting complex clinical data. This partnership focuses on enhancing the speed and quality of drug development by improving how clinical trial data is collected and analyzed. For investors, this partnership highlights AstraZeneca's efforts to integrate advanced technology into its research operations, potentially reducing development costs and accelerating time to market. Oracle’s role emphasizes the growing importance of AI in the pharmaceutical industry.